DCUN1D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.933200E-01
Normal-vs-Stage2
8.240400E-01
Normal-vs-Stage3
4.346400E-02
Normal-vs-Stage4
6.221600E-01
Stage1-vs-Stage2
9.886800E-01
Stage1-vs-Stage3
9.035700E-02
Stage1-vs-Stage4
4.033000E-01
Stage2-vs-Stage3
1.234550E-01
Stage2-vs-Stage4
4.964200E-01
Stage3-vs-Stage4
2.153200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.006000E-01
Normal-vs-AfricanAmerican
6.655600E-01
Normal-vs-Asian
5.420200E-01
Caucasian-vs-AfricanAmerican
1.731560E-01
Caucasian-vs-Asian
6.763200E-01
AfricanAmerican-vs-Asian
2.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.075400E-01
Normal-vs-Female
8.272800E-01
Male-vs-Female
5.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.408400E-01
Normal-vs-Age(41-60Yrs)
8.096400E-01
Normal-vs-Age(61-80Yrs)
5.607000E-01
Normal-vs-Age(81-100Yrs)
3.395200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.890200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.624200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.767600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.602200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.216100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.840000E-01
Normal-vs-Daily Drinker
1.923600E-01
Normal-vs-Weekly Drinker
4.511800E-01
Normal-vs-Occasional Drinker
8.294800E-01
Normal-vs-Social Drinker
9.570600E-01
Non Drinker-vs-Daily Drinker
2.274800E-01
Non Drinker-vs-Weekly Drinker
9.768200E-01
Non Drinker-vs-Occasional Drinker
9.295700E-02
Non Drinker-vs-Social Drinker
1.946170E-01
Daily Drinker-vs-Weekly Drinker
2.744400E-01
Daily Drinker-vs-Occasional Drinker
1.632360E-02
Daily Drinker-vs-Social Drinker
3.578200E-02
Weekly Drinker-vs-Occasional Drinker
1.771240E-01
Weekly Drinker-vs-Social Drinker
2.789800E-01
Occasional Drinker-vs-Social Drinker
7.665400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.302200E-01
Normal-vs-Grade 2
2.840200E-02
Normal-vs-Grade 3
4.310000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.649700E-02
Grade 1-vs-Grade 3
3.098200E-02
Grade 1-vs-Grade 4
2.302200E-01
Grade 2-vs-Grade 3
3.658800E-01
Grade 2-vs-Grade 4
2.840200E-02
Grade 3-vs-Grade 4
4.310000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.831000E-01
Normal-vs-NonDiabetic
6.349400E-01
Diabetic-vs-NonDiabetic
4.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.369000E-01
Normal-vs-NoPancreatitis
6.503800E-01
Pancreatitis-vs-NoPancreatitis
8.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.349000E-01
Normal-vs-N1
8.441200E-01
N0-vs-N1
2.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.141400E-01
Normal-vs-TP53-NonMutant
6.793000E-01
TP53-Mutant-vs-TP53-NonMutant
3.454300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
